Ganetespib
Other name
-
International/Other brands
-
Groups
Investigational
Structure
Prescription products
| Name | Dosage | Strength | Route | Labeller |
|---|---|---|---|---|
| No data available. | ||||
Target
Not Available
Description
Ganetespib is under investigation for the treatment of BREAST CANCER, Small Cell Lung Cancer, Acute Myeloid Leukaemia, and Myelodysplastic Syndrome.
Indications
-
Other indications
Her2-Positive Breast Cancer / Male Breast Cancer / Recurrent Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer
Mechaism of action
-
Absorption
-
Metabolism
-
Toxicity
-